Marcus Hompesch
CEO & Chairman of the Board @ProSciento, Inc.
Signup · Get unlimited contacts
WORK HISTORY
CEO & Chairman of the Board @ProSciento, Inc.
About ProSciento: The leading metabolism focused, specialty clinical R&D services provider.Our commitment: Advise - Advance - AchieveOur four divisions:CRD - Clinical Regulatory & Development ConsultingCRU - Clinical Research UnitCRO - Clinical Research Organization (Multi Center Research)CRI - Clinical Research Innovation
EDUCATION
University of Düsseldorf
M.D., Medicine
SKILLS
ABOUT MARCUS HOMPESCH
Training in Internal Medicine with particular interest in and focus on Diabetology, Diabetes Management and Clinical Research. After clinical and academic years transition into the clinical research and health care industry. Taking entrepreneurial roles, initially focused on diabetes disease management software. Since exclusively involved in establishing and managing specialized, quality and science driven clinical research organizations, focused on early phase diabetes, MASH / MASLD and obesity drug and device development programs.Specialties: Early phase clinical drug and device development in Diabetes, MASH / MASLD and Obesity. Scientific expertise in designing phase 1 and 2 clinical studies with particular emphasis on meaningful (decision enabling) mechanistic and proof of concept studies.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.